1287 related articles for article (PubMed ID: 20092558)
21. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
22. [Effects of huannao yicong recipe extract on the learning and memory and related factors of Abeta generation in the brain of APP transgenic mice].
Li H; Liu MF; Liu JG; Liu LT; Guan J; Cai LL; Hu J; Wei Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):90-4. PubMed ID: 23596795
[TBL] [Abstract][Full Text] [Related]
23. Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice.
Saura CA; Chen G; Malkani S; Choi SY; Takahashi RH; Zhang D; Gouras GK; Kirkwood A; Morris RG; Shen J
J Neurosci; 2005 Jul; 25(29):6755-64. PubMed ID: 16033885
[TBL] [Abstract][Full Text] [Related]
24. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
Sadleir KR; Popovic J; Vassar R
J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
[TBL] [Abstract][Full Text] [Related]
25. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
[TBL] [Abstract][Full Text] [Related]
26. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model.
Kimura R; Ohno M
Neurobiol Dis; 2009 Feb; 33(2):229-35. PubMed ID: 19026746
[TBL] [Abstract][Full Text] [Related]
27. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
28. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
[TBL] [Abstract][Full Text] [Related]
29. Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer's disease therapy.
Tarif AMM; Huhe H; Ohno M
Psychopharmacology (Berl); 2024 May; 241(5):975-986. PubMed ID: 38197930
[TBL] [Abstract][Full Text] [Related]
30. Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease.
Devi L; Ohno M
PLoS One; 2013; 8(10):e77335. PubMed ID: 24146979
[TBL] [Abstract][Full Text] [Related]
31. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice.
Ohno M; Cole SL; Yasvoina M; Zhao J; Citron M; Berry R; Disterhoft JF; Vassar R
Neurobiol Dis; 2007 Apr; 26(1):134-45. PubMed ID: 17258906
[TBL] [Abstract][Full Text] [Related]
32. Effects of alcohol intake on cognitive function and β-amyloid protein in APP/PS1 transgenic mice.
Gong YS; Hou FL; Guo J; Lin L; Zhu FY
Food Chem Toxicol; 2021 May; 151():112105. PubMed ID: 33737111
[TBL] [Abstract][Full Text] [Related]
33. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
[TBL] [Abstract][Full Text] [Related]
34. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
[TBL] [Abstract][Full Text] [Related]
35. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
[TBL] [Abstract][Full Text] [Related]
36. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
[TBL] [Abstract][Full Text] [Related]
37. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
Hook G; Yu J; Toneff T; Kindy M; Hook V
J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198
[TBL] [Abstract][Full Text] [Related]
38. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
39. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
40. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
